| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8822792 | European Journal of Radiology | 2018 | 9 Pages |
Abstract
Hepatic perfusion CT yields early imaging biomarkers for predicting overall survival in HCC patients treated with sorafenib.
Keywords
SSDEmRECISTECOG PSDLPTACECTDIVOLDCPFOVROIROCautomatic tube current modulationImaging biomarkertransarterial chemoembolizationHAICHCCα-fetoproteinMRIsize-specific dose estimateoverall survivalAFPMagnetic resonance imagingcomputed tomographySorafenibDynamic contrast-enhanced ultrasoundHepatic arterial infusion chemotherapyDose-length productmodified Response Evaluation Criteria in Solid Tumorsregion of interestField of viewEastern Cooperative Oncology Group Performance Statusdes-γ-carboxy prothrombinHepatocellular carcinomareceiver operating characteristic
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Yuko Nakamura, Tomokazu Kawaoka, Toru Higaki, Wataru Fukumoto, Yukiko Honda, Makoto Iida, Chikako Fujioka, Masao Kiguchi, Hiroshi Aikata, Kazuaki Chayama, Kazuo Awai,